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In the computation of excess cancers and mortalities in this paper, a conversion to SI units of two
variables was inadvertently omitted. The correction lowered the risks by varying degrees of
magnitude. The corrected results are given in the following tables. The secondary particle
contribution has been lowered by a factor of 2 for the total risk at 10 g/cm 2. The conclusions
remain the same with the exception of specific referenced numerical risks which have been
corrected herein. The authors apologize for these errors and regret any inconvenience this






























This study investigated radiation exposures and cancer induction/mortality risks for several
major solar particle events (SPE's). The SPE's included in this study are: February 1956,
November 1960, August 1972, October 1989, and the September, August, and October 1989
events combined. The three 1989 events were treated as one since all three could affect a single
hmar or Mars mission. A baryon transport code was used to propagate particles through aluminum
and tissue shield materials. This study utilized a free space environment for all calculations.
Results show the 30-day blood forming organs (BFO) limit of 25 rein was surpassed by all five
events using 10 g/cm 2 of shielding. The BFO limit is based on a depth dose of 5 cm of tissue,
while this study utilized a more detailed shield distribution of the blood forming organs. A
comparison between the 5 cm depth dose and the dose found using the BFO shield distribution
shows the 5 cm depth value slightly higher than the BFO dose. The annual limit of 50 rein was
exceeded by the August 1972, October 1989, and the three combined 1989 events with 5 g/cm 2 of
shielding. Cancer mortality risks ranged from 1.5 to 17 % at 1 g/cm 2 and 0.5 to 1.1% behind
10 g/cm 2 of shielding for the five events. These ranges correspond to those for a 45 year old male.
It is shown that secondary particles comprise about 1/3 of the total risk at 10 g/cm 2 of shielding.
Utilizing a computerized Space Shuttle shielding model to represent a typical spacecraft





radiationsarelimited in spatialextentandcanlargelybeavoided,thelow intensityGCR'sare
alwayspresentandtheSPE'sarepotentiallyof highintensityalthoughlimited in timeandspatially
unavoidableexceptdeepwithin theEarth'smagneticfield. A largeSPEduringalunaror Mars
mission,wherethespacecraftisnotprotectedbytheEarth'sgeomagneticfield, couldhaveacuteas
well aschronicadversehealtheffectsonimproperlyshieldedcrewmembers(Townsendet al.,







currentlyusedbyNASA. Canceriskswereattainedfor eachorganandsummedto giveatotal
risk of excesscancersandcancermortalitiesfrom theseSPE's.To illustratetheimportanceof
secondaryparticles,riskswerecalculatedandshownfor boththeprimaryandsecondaryparticles










(CAM) model(Billings, Yucker,1973)in ordertoobtainorgandosesbehindvariousthicknesses
of aluminumshielding.TheCAM modelwasdevelopedin theearly1970's,andwith updates
remainsasoneof thebestgeometricalandanthropomorphicallycorrectcomputermodelsavailable.
It is basedon50thpercentilestandingU.S.Air Forceman.
Riskswereassignedto eachorganbasedmostlyondatacollectedin areportto theNational
Institutesof Health(NIH) concerningradioepidemiologicaltables(Rall,etal., 1985).Therisk
coefficientsusedbytheNIH workinggroupcouldhavesubstantialuncertaintiesassociatedwith
theage-andsex-specificvalues(NCRP98, 1989).Onereasonfor thisuncertaintystemsfrom
transformingmortality ratesto incidenceratesbasedonvital statisticsdata(NCRP98, 1989).The
linearquadratic(L-Q) equationusedin theNationalCouncilonRadiationProtectionand
MeasurementsreportNo.98 (NCRP98),wasderivedby scalingthelinearBiologicalEffectsof
IonizingRadiation(BEIR)coefficients(NAS/ NRC, 1980) by a factor related to low or high
doses at low dose rates. The NCRP 98 committee defines acute and protracted doses using 5
rad/day as a dividing line. A dose received at a rate greater than 5 rad/day is considered acute
whereas less than 5 rad/day is a protracted dose. All the doses discussed in this study fall under
the acute situation. This factor is termed the Dose Rate Reduction Factor (DRRF) (NCRP 98,
1989). The L-Q coefficient for the acute situation is:
Risk coefficient = BEIR coefficient x D [1+1._6 ] Eq. 2.1(DRRF)
where: D = the acute dose in gray (Gy),
1.16 Gy = the assumed cross-over dose point for which the dose-squared contribution
equals the linear contribution (Rall et al., 1985).
The assumed DRRF is 2.5 according to the NCRP 98. These coefficients were then used to
express predicted lifetime risks and mortalities from cancer among 1000 persons, both age- and
sex-specific. An L-Q relationship was used for all organs excluding the thyroid, where a linear






Dr = doseusedin NCRP98 tables
ET= specificcancerexcessassociatedwith doseD,r.
Thelifetimeradiationriskscomputedin thisreportwererepresentativeof cancersitesin whichthe
NIH Working Groupprovidedrisk coefficients(Rall, etal., 1985)andfor "other" cancers.It has
beenshownthatmostcancerscanbecausedbyradiation;however,thereis little ornoevidenceof
radiationcausingchroniclymphocytic(CL) leukemia(NCRP98,1989).Theleukemiarisksgiven
hereindonot includethis typeof malignancyandwill bedesignatedasthe"sumof non-CL
leukemia." Oneexcesscancerpermillion person-year-tadwasassignedfor"other" sitesby the
BEIR committeeandcoefficientswerethencomputedby assumingthemto beproportionalto
thosefor deathsfrom all cancers,exceptleukemia,in theatomicbombsurvivorsof bothsexes




Thisstudyuseddoseequivalentnumbersin placeof absorbeddosestoaccountfor thehigher
LET valuesassociatedwith spaceradiation. It shouldbenotedthattherisksshownin thisstudy




ThecodeBRYNTRN wasrun for six pastsignificantSPE'sincludingFebruary1956,
November1960,August1972,August1989,September1989,andOctober 1989. The 1989
events were combined for one case since all three SPE's could have affected a single lunar or Mars
mission. The October 1989 flare was also used singularly because of its size. The code was
modified to transport SPE particles through seven different depths of aluminum and 16 different
thicknesses of tissue (H20 in the code). BRYNTRN was set up such that the particles were
transported through the 16 depths of tissue following the propagation through each thickness of
aluminum. Organ doses were interpolated using these data in conjunction with organ shield
distributions from the CAM model. The shield distributions are obtained by selecting a dose point
in the organ and ray tracing isotropically to outside the body. These organ doses could then be
applied to equation 2.2 to obtain organ-, age-, and sex-specific risks. A short code, RISK, was
written to accomplish this task. To show the contribution of secondary particles, the output of
BRYNTRN was modified to give doses from both secondary and primary particles. Following
this, the same procedure described above was followed to obtain risks. This was done only for the
August 1972 flare. To show organ doses and risks in a situation other than slab geometries, two
dosimeter locations (DLOC) on the current Space Shuttle were chosen, historically the points with
the highest and lowest dose readouts, and put into free space for the August 1972 flare. These
results were obtained by interpolating the BRYNTRN output twice, first through the Shuttle using
its shield distribution model, and then through the body. Risks were then found following the
methodology described above.
4. RESULTS
Selected organ doses and dose equivalents vs. thickness of aluminum shielding are
shown in figures 1 - 10. These plots give a good indication of where additional shielding produces
only a small decrease in doses. A comparison of the BFO, skin, and eye doses with the limits is
given in tables 1 - 5. One should recall that all the doses and risks shown herein are representative
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of freespace,outsidetheearth'smagnetosphere.As canbeseen,theBFO limit isexceededuntil
10g/cm2,table1,for theAugust1972flare,andthisdoesnot takeinto accounttheGCR
contribution.Tables6 - 25showtheorgan-,age-,andsex-specificcancerandmortality risksfor
thedifferentflaresbehind1and10g/cm2of A1shielding. It shouldbenotedthatdueto thelackof
asuitablefemalemodelatthetimethisstudywasconducted,therisk from thebreastswasleft out
for thefemale,This is significantin thatthebreastsgenerallyrepresentthegreatestsingleorgan
cancerisk to thefemaleandtheexposureisexpectedto berelativelyhigh (Shaversetal., 1991).
Uponcompletionof afemalemodel,currentlybeingworkedon,riskswill becalculatedand
documented.Therisk contributionfrom secondaryparticlescanbeseenin tables26 - 29and





werecomparedwith theBFO,skin,andeyecomputeddoses.It canbeseenthat for eachof the
SPE's,theBFOdosesexceededthecurrent30-daylimit of 25reinusing10g/cm2of aluminum
shielding. It shouldbestatedthatthelimits for SpaceExplorationInitiative (SEI)classmissions
couldvaryfrom currentlimits dependingonothernominalrisksassociatedwith theseflightsand
thefeasibilityof stayingbelowapredeterminedoselimit. Theannualimit, 50rem,was
surpassedbytheAugust1972,October1989,andthethree1989eventscombinedbehind5 g/cm2
of aluminum.Graphsof dosesanddoseequivalentsfor otherorgansvs.shieldthicknessare
shownin figures1- 10. Thesefiguresgive arepresentationof wheremoreshieldingyields small
changesin dosefor eachevent.This appearsto bebetween10and15g/cm2 onaveragefor the
flaresusedin thisstudy. Tables6 - 25displayage-andsex-specificrisksbasedon theorgan
dosesfrom eachSPE.Theseriskswerecalculatedbehind1and10g/cm2of shielding. Therisks
aredisplayedasexcesscancersandcancermortalitiesper1000people.Forthethreecombined
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1989eventsbehind10g/cm2of shielding,a25yearold male would have approximately a 2.5%
risk of obtaining a fatal cancer. This doesn't take into account the GCR contribution which would
add to this risk. To show the contribution of secondary particles, tables 26 - 29 show excess
cancers and cancer morialities for a 25 year old male due to both primary protons and secondary
particles. The secondary particle contribution is approximately 1/3 of the total risk at 10 g/cm 2.
The last set of tables, 30 - 34, show organ doses and their respective risks at two representative
dosimeter locations on the current Space Shuttle for the August 1972 event in free space. It can be
seen that the annual limit of 50 rem for the BFO was surpassed at DLOC #2 and was approached at
DLOC #1. It should be noted that these two dosimeter locations are historically the highest (#2)
and lowest (#1) dose points recorded during flights. The measured crewmember exposures have
historically averaged approximately 110% of the DLOC #1 dose.
The flare doses behind varying depths of A1 obtained with BRYNTRN correlated well with
previously published values. As a reminder, these doses and risks do not include the additional
exposure from GCR's which would be significant on an SEI mission. The results of this study
give a detailed assessment of risks associated with major SPE's. The question of how much
shielding is required for a "storm shelter" will be based on an amount equal to or greater than that
shielding required to keep all doses at or below a level such that the mortality risk to the
crewmembers stays below a predetermined value (e.g., 3-5%). The total radiation risk would
require evaluations of contributions from the GCR as well as any onboard sources such as nuclear
power. This does not exclude the As Low As is Reasonably Achievable (ALARA) principle,
however; and it should be stressed that radiation limits of any kind, risk, or dose are established as
maximums and not quotas.
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DOSE EQUIVALENTS (REM) FROM THE AUGUST, SEPTEMBER,
& OCTOBER 1989 SPE'S IN FREE SPACE


















































































































































FEBRUARY 1956 SPE, EXCESS CANCER MORTALITIES PER 1000 PEOPLE BEHIND 1 g/cm**2 OF AI
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FEBRUARY 1956 SPE, EXCESS CANCER MORTALITIES PER 1000 PEOPLE BEHIND 10 g/cm**2 OF AI
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AUGUST 1972 SPE, EXCESS CANCER MORTALITIES PER 1000 PEOPLE BEHIND 1 g/cm**2 OF AI
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AUGUST 1972 SPE, EXCESS CANCER MORTALITIES PER 1000 PEOPLE BEHIND 10 g/cm**2 OF AI

































































SUM (NON-CL) KIDNEY & THYROID ALL OTHER TOTAL












































OCTOBER 1989 SPE, EXCESS CANCERS PER 1000 PEOPLE BEHIND 1 g/cm*°2 OF AI
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OCTOBER 1989 SPE, EXCESS CANCER MORTALITIES PER 1000 PEOPLE BEHIND 1 g/cm°*2 OF AI


























































































































OCTOBER 1989 SPE, EXCESS CANCERS PER 1000 PEOPLE BEHIND 10 g/cm**2 OF AI
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OCTOBER 1989 SPE, EXCESS CANCER MORTALITIES PER 1000 PEOPLE BEHIND 10 g/cm**2 OF AI

























































































































































































































































AUG., SEP., & OCT. 1989 SPE'S, EXCESS CANCER MORTALITIES PER 1000 PEOPLE
BEHIND 1 g/cm**2 OF AI
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& OCT. 1989 SPE'S, EXCESS CANCER MORTALITIES PER 1000 PEOPLE
g/cm**2 OF AI
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Excess Cancer Mortalities per 1000 25 yr. old Males Behind 10 g/cm*'2 of AI
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EXCESSCANCERSPER1000PEOPLEATSTSDLOC2
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transport code was used to propagate particles through aluminum and tissue shield
materials. This study used a free space environment for all calculations. Results
show the 30-day blood forming organs (BFO) limit of 25 rem was surpassed by all five
events using 10 g/cm2 of shielding. The BFO limit is based on a depth dose of 5 cm of
tissue, while this study used a more detailed shield distribution of the BF0. A com-
parison between the 5 cm depth dose and the dose found using the BFO shield distribu-
tion shows the 5 cm depth value slightly higher than the BFO dose. The annual limit
of 50 rem was exceRded by the August 1972, October 1989, and three combined 1989
events with 5 g/cmL of shielding. Cancer mortality risks ranged from 1.5 to 17% at I
g/cm_ and 0.5 to 1.1% behind 10 g/cm2 of shielding for the five events. These ranges
correspond to those for a 45-year old male. It is shown that secondary particles
comprise about i/3 of the total risk at 10 g/cm2 of shielding. Using a computerized
Space Shuttle shielding model to represent a typical spacecraft configuration in
free space at the August 1972 SPE, average crew doses exceeded the BFO limit.
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